Analysis of Biomarkers in Patients With Acute Myeloid Leukemia After Allogeneic Stem Cell Transplantation Treated With Menin Inhibition.

Integrative "Omics" Approaches for Leukemia Target Identification and Matched Therapeutic Intervention

NCT06626893 ·Status: RECRUITING ·Phase: NA

Improving Risk Assessment of AML With a Precision Genomic Strategy to Assess Mutation Clearance

NCT02756962 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Biomarkers in Patients With Acute Myeloid Leukemia

NCT01138319 ·Status: COMPLETED

Biomarkers in Blood Samples From Patients With Acute Myeloid Leukemia

NCT01385150 ·Status: COMPLETED

Genetics Study of Tissue Collected From Patients With Acute Myeloid Leukemia

NCT00898092 ·Status: UNKNOWN

Biomarkers in Samples From Adult Patients With Acute Myeloid Leukemia Who Failed Existing Standard-of-Care Treatment

NCT01421862 ·Status: UNKNOWN

Study of Blood and Bone Marrow Samples in Patients With Chronic Myelogenous Leukemia Enrolled on a CALGB Clinical Trial

NCT01004640 ·Status: UNKNOWN

Biomarker Study of Chemotherapy Resistance and Outcomes in Samples From Older Patients With Acute Myeloid Leukemia

NCT01421875 ·Status: COMPLETED

Studying Biomarkers in Samples From Younger Patients With Acute Myeloid Leukemia

NCT01642121 ·Status: COMPLETED

Biomarkers in Bone Marrow Samples From Young Patients With Acute Myeloid Leukemia

NCT01298414 ·Status: COMPLETED

Multidrug Resistance Genes in Patients With Acute Myeloid Leukemia

NCT00898456 ·Status: ACTIVE_NOT_RECRUITING

Exploring Disease Immunogenicity and the Immunological Effects of Hypomethylating Agents in Acute Myeloid Leukemia

NCT03789981 ·Status: ACTIVE_NOT_RECRUITING

Identifying Cancer Genes in in Blood and Bone Marrow Samples From Patients With Acute Myeloid Leukemia

NCT00897182 ·Status: COMPLETED

Study of Bone Marrow and Blood Samples in Patients With Untreated Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia Enrolled on Clinical Trial CALGB-9621 or CALGB-9720

NCT01004965 ·Status: COMPLETED

Evaluation of a New Anti-cancer Immunotherapy in Adult Acute Myeloid Leukemia Patients With a Suboptimal Clinical Response to Induction Chemotherapy

NCT01051063 ·Status: COMPLETED ·Phase: PHASE1

Biomarkers in Samples From Patients With B-Cell Acute Lymphoblastic Leukemia

NCT01505699 ·Status: COMPLETED

Cytogenetic Studies in Acute Leukemia and Multiple Myeloma

NCT00048958 ·Status: ACTIVE_NOT_RECRUITING

SCH 727965 in Patients With Acute Myelogenous Leukemia and Acute Lymphoblastic Leukemia (P04717AM2)(TERMINATED)

NCT00798213 ·Status: TERMINATED ·Phase: PHASE2

Evaluation of a New Anti-cancer Immunotherapy After Chemotherapy in Adult Patients With Acute Myeloid Leukemia (AML)

NCT00725283 ·Status: COMPLETED ·Phase: PHASE1

Harnessing the Immunosuppressive Leukemic Microenvironment to Engineer T Cells With Enhanced Anti-tumor Functionality

NCT07743047 ·Status: NOT_YET_RECRUITING

A Study of Revumenib and Mezigdomide in People With Leukemia

NCT07356154 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Study of MEN1112 Intravenous Infusion in Relapsed or Refractory Acute Myeloid Leukemia

NCT02353143 ·Status: TERMINATED ·Phase: PHASE1

Biomarkers in Samples of Bone Marrow From Patients With Acute Myeloid Leukemia

NCT01290107 ·Status: COMPLETED

Diagnostic Study of Patients With Acute Lymphoblastic Leukemia or Acute Promyelocytic Leukemia

NCT00003861 ·Status: ACTIVE_NOT_RECRUITING

Diagnostic Platform to Perform Centralized and Standardized Rapid Molecular Diagnosis by Next Generation Sequencing (NGS) in Patients Diagnosed With Acute Myeloid Leukemia.

NCT03311815 ·Status: COMPLETED